Screener
Summit Therapeutics SMMT Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Other current liabilities | 1,148 | 2,283 |
| Total current liabilities | 83,266 | 72,988 |
| Non-current liabilities: | ||
| Operating lease liabilities, net of current portion | 16,859 | 17,502 |
| Other non-current liabilities | 1,799 | 1,832 |
| Total liabilities | 101,924 | 92,322 |
| Commitments and contingencies (Note 12) | ||
| Stockholders' equity: |
Item 1. Financial Statements.
FAQ
- What is Summit Therapeutics's operating lease liabilities?
- Summit Therapeutics (SMMT) reported operating lease liabilities of $16.86M in Q1 2026.
- How has Summit Therapeutics's operating lease liabilities changed year-over-year?
- Summit Therapeutics's operating lease liabilities increased by 479.9% year-over-year, from $2.91M to $16.86M.
- What is the long-term trend for Summit Therapeutics's operating lease liabilities?
- Over 5 years (2020 to 2025), Summit Therapeutics's operating lease liabilities has grown at a 197.6% compound annual growth rate (CAGR), from $75K to $17.5M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Summit Therapeutics's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude